Case ReportA Drug–drug Interaction Between Cyclosporine and Nystatin (cas 1400-61-9)
-
Add time:09/02/2019 Source:sciencedirect.com
We present a case of increased cyclosporine concentration and liver function right after the combinational use of cyclosporine and nystatin, which indicated a drug–drug interaction between them. Both the concentration and liver function were decreased after discontinuation of nystatin and remained normal after taking on cyclosporine again. To our knowledge, this is the first case report of the interactions between nystatin and cyclosporine. Enteric P-glycoprotein could play an important role in the pharmacokinetic profile of cyclosporine, which needs further identification by physicians and pharmacists.
We also recommend Trading Suppliers and Manufacturers of Nystatin (cas 1400-61-9). Pls Click Website Link as below: cas 1400-61-9 suppliers
Prev:Comparison of the efficacy of indocyanine green-mediated photodynamic therapy and Nystatin (cas 1400-61-9) therapy in treatment of denture stomatitis
Next:Stability and efficacy of combined Nystatin (cas 1400-61-9) and chlorhexidine against suspensions and biofilms of Candida albicans) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Preparation, physicochemical characterization and anti-fungal evaluation of the Nystatin (cas 1400-61-9)-loaded Eudragit RS100/PLGA nanoparticles09/09/2019
- The role of sterols in the lipid vesicle response induced by the pore-forming agent Nystatin (cas 1400-61-9)09/08/2019
- Identification of multi-targeted anti-migraine potential of Nystatin (cas 1400-61-9) and development of its brain targeted chitosan nanoformulation09/07/2019
- A promising Nystatin (cas 1400-61-9) nanocapsular hydrogel as an antifungal polymeric carrier for the treatment of topical candidiasis09/06/2019
- Original Research ArticleEvaluation of mucoadhesive oral films containing Nystatin (cas 1400-61-9)09/05/2019
- Development of a gum base formulation for Nystatin (cas 1400-61-9); a new drug delivery approach for treatment of oral candidiasis09/04/2019
- Stability and efficacy of combined Nystatin (cas 1400-61-9) and chlorhexidine against suspensions and biofilms of Candida albicans09/03/2019
- Comparison of the efficacy of indocyanine green-mediated photodynamic therapy and Nystatin (cas 1400-61-9) therapy in treatment of denture stomatitis09/01/2019